Low-risk PCa patients with a CRMP4 promoter methylation rate > 18.00% based on preoperative biopsy were more likely to undergo a GS upgrade to ≥8 based on postoperative pathologic evaluation. Here, DPYSL3 is linked to posterior cortical atrophy.